Dianthus Therapeutics Inc

DNTH

Add to Watchlist

82.490USD

+0.600+0.73%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

4.51BMarket Cap

LossP/E TTM

Dianthus Therapeutics Inc

82.490

+0.600+0.73%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-18

Previous score

10.00

Change

The current institutional shareholding score of Dianthus Therapeutics Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 99.70%, representing a quarter-over-quarter decrease of 0.93%. The largest institutional shareholder is Steven Cohen, holding a total of 623.17K shares, representing 1.18% of shares outstanding, with 0.23% increase in holdings.